Archives for May 17, 2015

Emerging technologies will help take probiotics and other digestive health ingredients to the next level: Bayer HealthCare Scientist

Emerging methodologies and technologies such as the Smart Pill, non-invasive molecular methods using exfoliated epithelial cells, and uBiome, need further consideration and evaluation from key stakeholders to identify their validity as markers of...

Extending GMPs to ingredient suppliers would fix gap in original rule, stakeholders say

A recently filed citizen's petition asking FDA to extend GMP requirements to ingredient manufacturers met with a cautious but generally positive reception among industry stakeholders. Having ingredient suppliers stand outside this aspect of the law was...

Soapbox

Body of endocannabinoid research makes compelling case for wider use

An exciting new area of research involves the endocannabinoid system (ECS) and the phyto-cannabinoid cannabidiol (CBD).  

FDA says no to CBD in supplements

In a recently updated communication on marijuana, the Food and Drug Administration has flatly stated that products based on cannabidiol (CBD), a non-narcotic fraction of Cannabis sativa, cannot be marketed as dietary supplements.  The reason? A...